We therefore hypothesized that global activation of CD8+ CTLs may correlate with GV disease activity and that this activation was responsible for the progress of depigmentation and an increased frequency of associated autoimmune disorders in GV patients. The gene discussed is CD8A; the disease is Autoimmunity.